KGKaival Gundavda

Kaival Gundavda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kaival Gundavda has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Defining the Role of Staging Laparoscopy in the Management of the Gallbladder Cancers: A Single Institution Experience

    by Niket Shah, Shraddha Patkar, Gurudutt P. Varty, Kaival Gundavda, Mahesh Goel

    Introduction: Despite advances in imaging and extensive staging work‐up, occult metastases may still be encountered at laparotomy in patients with apparently resectable gallbladder cancer (GBC), resulting in nontherapeutic surgery. This study evaluates the incremental yield of staging laparoscopy (SL) in detecting radiologically occult metastases in resectable GBC and its role in routine staging. Methods: A prospectively maintained database of patients operated for GBC at a high volume institution was analyzed to calculate the diagnostic yield of SL and the percentage of missed metastases by modern imaging analysis but subsequently diagnosed on SL. In the univariate and multivariate logistic regression, the following binary variables were evaluated to identify predictors of metastasis on SL: (i) NACT (neoadjuvant chemotherapy) receipt: yes versus no; (ii) serum carbohydrate antigen 19–9 (CA19‐9) level: > 1000 u/mL versus ≤ 1000 U/mL; (iii) 18 fluorodeoxyglucose positron emission tomography/computed tomography ( 18 FDG PET/CT) scan result: equivocal versus negative (positive results were excluded from this analysis as they would not have proceeded to SL without additional workup); (iv) clinical stage: locally advanced versus early; (v) incidental GBC: yes versus no; (vi) tumor grade: moderate/poorly differentiated versus well differentiated. Results: The SL was incorporated into the diagnostic and management pathway of 330 GBC patients. SL was performed (i) as a staging prior to a planned radical cholecystectomy ( n = 210, 63.6%) and (ii) prior to initiating systemic therapy ( n = 120, 36.4%). The diagnostic yield of SL for detection of metastases over cross‐sectional imaging was 11.5% ( n = 38). Reasons for inoperability on laparotomy were metastatic 16b1 lymph node (LN) ( n = 19, 50%), locally unresectable disease ( n = 15, 39.5%), peritoneal metastasis ( n = 2, 5.3%), and liver metastasis ( n = 2, 5.3%). The reason for locally unresectable disease was right hepatic artery encasement at the porta hepatis. Regression analysis showed that the significant predictors for metastatic disease on SL were equivocal uptake on 18 FDG PET/CT scan ( p = < 0.001) and prior NACT ( p = 0.026). Conclusion: SL provides an incremental detection of radiologically occult metastasis in up to 11.5% patients. The study underscores the benefit of SL and suggests that it should be incorporated in the management of all GBC patients.

  • Open Access

    Predicting clinical benefit response after neoadjuvant chemotherapy in locally advanced gallbladder cancer: retrospective analysis

    by Shraddha Patkar, Kaival Gundavda, Kaushik Polusany, Raghav Yelamanchi, Gurudutt P Varty, Niket Shah, Akash Pawar, Vikas Ostwal, Anant Ramaswamy, Prabhat Bhargava, et al.

    Background: Neoadjuvant chemotherapy is increasingly used in patients with locally advanced gallbladder cancer (LAGBC). This study investigated factors affecting clinical benefit response (CBR) to neoadjuvant chemotherapy for LAGBC. Methods: All consecutive patients with LAGBC following neoadjuvant chemotherapy, from January 2013 to December 2022, were analyzed for clinical and radiological responses as well as survival outcomes. CBR rates, resectability, and their impact on survival were evaluated. In addition, factors predicting CBR were identified and a predictive nomogram model was developed. Results: Of 401 patients with LAGBC undergoing neoadjuvant chemotherapy, 303 (75.5%) exhibited a CBR. The median overall survival (OS) in patients with a CBR was 25 months, compared with 8.5 months for those without a CBR. Factors predicting a worse CBR rate included age ≥ 55.5 years (hazard ratio (HR) 2.17; 95% confidence interval (c.i.) 1.29 to 3.65), Eastern Cooperative Oncology Group (ECOG) performance status ≥ 1 (HR 2.5; 95% c.i. 1.117 to 5.59), platelet count ≥ 468 × 109/l (HR 2.86; 95% c.i. 1.12 to 6.74), tumour (T) size ≥ 2.1 cm (HR 3.4; 95% c.i. 1.70 to 6.80), T stage ≥ T3 (HR 3.26; 95% c.i. 1.22 to 8.74), and a systemic immune-inflammation index (SII) ≥ 1265.90 (HR 2.34; 95% c.i. 1.27 to 4.30). Of the patients with a CBR, 86% underwent curative surgical resection, with median OS improved to 29.54 months, compared with 11.86 months for those without resection (P < 0.01). Conclusion: A CBR was achieved in 75.5% of patients, with curative surgical resection in 86%. A CBR was associated with improved OS. Anatomical (T size, T stage) and immune–inflammation markers (platelet count, SII) were found to predict a CBR, and could help identify responders to neoadjuvant chemotherapy. This could have implications for treatment strategies, but requires validation in further prospective studies.

  • Open Access

    Correlation between Tomographic and Histopathological Staging in Upfront Resected Gastric Cancer: Enhancing Diagnostic Accuracy in the Era of Perioperative Therapy

    by Kaival Gundavda, Aishvarya Shri Rajasimman, Shraddha Patkar, Renish Chhatrala, Akshay D. Baheti, Purvi Haria, Manjushree Kolhe, Manish Bhandare, Vikram Chaudhari, Shailesh V. Shrikhande

    Purpose This study aimed to assess the diagnostic accuracy of multidetector contrast-enhanced computerised tomography (MDCT) and to establish a correlation between radiological and histopathological staging in upfront resected localised gastric cancers (GC). Methods All consecutive patients of resectable, localised GC who underwent upfront elective resection between 2010 and 2022 were included. The initial clinical staging determined during multidisciplinary meetings was compared with the pathological stage obtained after surgery. Subsequently, a retrospective, blinded review was conducted to assign a revised clinical staging, and accuracy was correlated. Results The analysis of 138 patients revealed varying accuracy of MDCT in determining the T stage (66.9% for T1/T2, 64.6% for T3, and 87.2% for T4) and N stage (60.8% for N0, 63.7% for N1, and 83.2% for N2). The accuracy for stage group ranged from 71 to 78.65%. There was weak agreement observed between the T, N, and overall stage on clinicopathological correlation. However, a blinded radiology review by oncoradiologists resulted in improved accuracy, particularly in T1/T2 disease, and also improved pathological stage correlation. Conclusions Although MDCT is a valuable initial staging tool for gastric cancer, we found weak agreement between the clinical and the pathological stages in upfront resected gastric cancers. By implementing an expert radiology review and standardising scanning and reporting protocols, we can significantly improve the accuracy and correlation of MDCT with pathology, even for T1/T2 disease. This may help in better selecting patients for upfront surgery versus perioperative chemotherapy, especially in resource-constrained settings.


  • Cystic bone Lesions: Diagnostic pitfalls and therapeutic considerations

    by Ashwin Prajapati, Ashish Gulia, Kaival Gundavda, Rajesh Botchu, Amit Janu


  • Optimal treatment strategies for borderline resectable liver metastases from colorectal cancer

    by Gurudutt P. Varty, Shraddha Patkar, Kaival Gundavda, Niket Shah, Mahesh Goel


  • ASO Visual Abstract: Prognostic Impact of Para-aortic Lymph Node Metastasis in Resected Nonpancreatic Periampullary Cancers

    by Kaival Gundavda, Amit Chopde, Avinash Pujari, Bhaskar Reddy, Akash Pawar, Anant Ramaswamy, Vikas Ostwal, Shraddha Patkar, Manish Bhandare, Shailesh V. Shrikhande, et al.

  • ASO Visual Abstract: Realizing Textbook Outcomes Following Liver Resection for Hepatic Neoplasms with Development and Validation of a Predictive Nomogram

    by Kaival K. Gundavda, Shraddha Patkar, Sadhana Kannan, Gurudutt P. Varty, Kunal Nandy, Tanvi Shah, Kaushik Polusany, Sohan Lal Solanki, Suyash Kulkarni, Nitin Shetty, et al.

  • Liver Resection for Hepatocellular Carcinoma: Recent Advances

    by Kaival K. Gundavda, Shraddha Patkar, Gurudutt P. Varty, Niket Shah, Karthik Velmurugan, Mahesh Goel


  • Open Access

    Realizing Textbook Outcomes Following Liver Resection for Hepatic Neoplasms with Development and Validation of a Predictive Nomogram

    by Kaival K. Gundavda, Shraddha Patkar, Sadhana Kannan, Gurudutt P. Varty, Kunal Nandy, Tanvi Shah, Kaushik Polusany, Sohan Lal Solanki, Suyash Kulkarni, Nitin Shetty, et al.

    Background: ‘Textbook Outcome’ (TO) represents an effort to define a standardized, composite quality benchmark based on intraoperative and postoperative endpoints. This study aimed to assess the applicability of TO as an outcome measure following liver resection for hepatic neoplasms from a low- to middle-income economy and determine its impact on long-term survival. Based on identified perioperative predictors, we developed and validated a nomogram-based scoring and risk stratification system. Methods: We retrospectively analyzed patients undergoing curative resections for hepatic neoplasms between 2012 and 2023. Rates of TO were assessed over time and factors associated with achieving a TO were evaluated. Using stepwise regression, a prediction nomogram for achieving TO was established based on perioperative risk factors. Results: Of the 1018 consecutive patients who underwent liver resections, a TO was achieved in 64.9% (661/1018). The factor most responsible for not achieving TO was significant post-hepatectomy liver failure (22%). Realization of TO was independently associated with improved overall and disease-free survival. On logistic regression, American Society of Anesthesiologists score of 2 (p = 0.0002), perihilar cholangiocarcinoma (p = 0.011), major hepatectomy (p = 0.0006), blood loss >1500 mL (p = 0.007), and presence of lymphovascular emboli on pathology (p = 0.026) were associated with the non-realization of TO. These independent risk factors were integrated into a nomogram prediction model with the predictive efficiency for TO (area under the curve 75.21%, 95% confidence interval 70.69–79.72%). Conclusion: TO is a realizable outcome measure and should be adopted. We recommend the use of the nomogram proposed as a convenient tool for patient selection and prognosticating outcomes following hepatectomy.